相关实验视频
Updated: May 1, 2026

08:02
Combination Radiotherapy in an Orthotopic Mouse Brain Tumor Model
Published on: March 6, 2012
16.4K
视神经质瘤在资源有限的环境中成功治疗了强度调节放射治疗:一个案例报告
Judith Naa Odey Tackie1, Ernestina Schandorf2, Patrick Bankah3
1National Centre for Radiotherapy, Oncology and Nuclear Medicine, Korle Bu Teaching Hospital, Accra, Ghana.
Ecancermedicalscience
|January 16, 2025
概括
视神经质瘤 (ONG) 是常见的儿科大脑瘤. 这一案例突出显示,即使在资源有限的环境中,在患有NGO的儿童中,使用先进的放射治疗成功保护了视力.
科学领域:
- 神经瘤学神经瘤学
- 儿科眼科 儿科眼科
- 辐射瘤学 辐射瘤学
背景情况:
- 视神经质瘤 (ONG) 是儿童最常见的视神经瘤.
- 这些良性,缓慢生长的瘤通常会影响20岁以下的人.
- 目前的治疗方法,如手术,具有显著的发病率和视力丧失的风险.
研究的目的:
- 报告一个儿科视神经质瘤病例.
- 用先进的放射治疗来证明有效的视力保护.
- 强调在管理非政府组织方面采用多学科方法的重要性.
主要方法:
- 一个案例报告,一个11岁的男孩患有左视神经质瘤.
- 通过对比增强的MRI证实诊断,显示视神经扩大.
- 治疗包括强度调节放射治疗 (IMRT).
主要成果:
- 通过IMRT获得成功的瘤控制.
- 在受影响的眼睛中维护视力.
- 在资源有限的环境中证明了先进放射治疗的可行性.
结论:
- 强度调节放射治疗为视神经质瘤管理提供了一个可行的选择.
- 先进的放射治疗技术可以在儿科患者中保持视力.
- 多学科,个性化的方法对于NGO的最佳结果至关重要.
相关概念视频
Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
Treatment Resistant Cancers
2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K

